These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 35234625)

  • 1. Immunogenicity of a recombinant VSV-Vectored SARS-CoV vaccine induced robust immunity in rhesus monkeys after single-dose immunization.
    Shan D; Tang X; Liu R; Pan D; Wang X; Ge J; Wen Z; Bu Z
    Virol Sin; 2022 Apr; 37(2):248-255. PubMed ID: 35234625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A recombinant VSV-vectored MERS-CoV vaccine induces neutralizing antibody and T cell responses in rhesus monkeys after single dose immunization.
    Liu R; Wang J; Shao Y; Wang X; Zhang H; Shuai L; Ge J; Wen Z; Bu Z
    Antiviral Res; 2018 Feb; 150():30-38. PubMed ID: 29246504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Methyltransferase-Defective Vesicular Stomatitis Virus-Based SARS-CoV-2 Vaccine Candidate Provides Complete Protection against SARS-CoV-2 Infection in Hamsters.
    Lu M; Zhang Y; Dravid P; Li A; Zeng C; Kc M; Trivedi S; Sharma H; Chaiwatpongsakorn S; Zani A; Kenney A; Cai C; Ye C; Liang X; Qiu J; Martinez-Sobrido L; Yount JS; Boyaka PN; Liu SL; Peeples ME; Kapoor A; Li J
    J Virol; 2021 Sep; 95(20):e0059221. PubMed ID: 34379509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of Immune Response Diversity in Rodents Vaccinated with a Vesicular Stomatitis Virus Vectored COVID-19 Vaccine.
    Wang S; Zhang C; Liang B; Wang W; Feng N; Zhao Y; Wang T; Guo Z; Yan F; Yang S; Xia X
    Viruses; 2022 May; 14(6):. PubMed ID: 35746599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Replication-Competent Vesicular Stomatitis Virus Vaccine Vector Protects against SARS-CoV-2-Mediated Pathogenesis in Mice.
    Case JB; Rothlauf PW; Chen RE; Kafai NM; Fox JM; Smith BK; Shrihari S; McCune BT; Harvey IB; Keeler SP; Bloyet LM; Zhao H; Ma M; Adams LJ; Winkler ES; Holtzman MJ; Fremont DH; Whelan SPJ; Diamond MS
    Cell Host Microbe; 2020 Sep; 28(3):465-474.e4. PubMed ID: 32798445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS vaccine based on a replication-defective recombinant vesicular stomatitis virus is more potent than one based on a replication-competent vector.
    Kapadia SU; Simon ID; Rose JK
    Virology; 2008 Jun; 376(1):165-72. PubMed ID: 18396306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid Protection from COVID-19 in Nonhuman Primates Vaccinated Intramuscularly but Not Intranasally with a Single Dose of a Vesicular Stomatitis Virus-Based Vaccine.
    Furuyama W; Shifflett K; Pinski AN; Griffin AJ; Feldmann F; Okumura A; Gourdine T; Jankeel A; Lovaglio J; Hanley PW; Thomas T; Clancy CS; Messaoudi I; O'Donnell KL; Marzi A
    mBio; 2022 Feb; 13(1):e0337921. PubMed ID: 35012339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical immunogenicity and efficacy of a candidate COVID-19 vaccine based on a vesicular stomatitis virus-SARS-CoV-2 chimera.
    Espeseth AS; Yuan M; Citron M; Reiserova L; Morrow G; Wilson A; Horton M; Rukhman M; Kinek K; Hou F; Li SL; Li F; Choi Y; Heidecker G; Luo B; Wu G; Zhang L; Strable E; DeStefano J; Secore S; Mukhopadhyay TK; Richardson DD; Sayeed E; Welch LS; Bett AJ; Feinberg MB; Gupta SB; Cooper CL; Parks CL
    EBioMedicine; 2022 Aug; 82():104203. PubMed ID: 35915046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A vesicular stomatitis virus-based prime-boost vaccination strategy induces potent and protective neutralizing antibodies against SARS-CoV-2.
    Kim GN; Choi JA; Wu K; Saeedian N; Yang E; Park H; Woo SJ; Lim G; Kim SG; Eo SK; Jeong HW; Kim T; Chang JH; Seo SH; Kim NH; Choi E; Choo S; Lee S; Winterborn A; Li Y; Parham K; Donovan JM; Fenton B; Dikeakos JD; Dekaban GA; Haeryfar SMM; Troyer RM; Arts EJ; Barr SD; Song M; Kang CY
    PLoS Pathog; 2021 Dec; 17(12):e1010092. PubMed ID: 34914812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment of replication-competent vesicular stomatitis virus recapitulating SADS-CoV entry.
    Zhu Z; Han Y; Gong M; Sun B; Zhang R; Ding Q
    J Virol; 2024 May; 98(5):e0195723. PubMed ID: 38557247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pseudotyped vesicular stomatitis virus for analysis of virus entry mediated by SARS coronavirus spike proteins.
    Fukushi S; Watanabe R; Taguchi F
    Methods Mol Biol; 2008; 454():331-8. PubMed ID: 19057867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Recombinant VSV-Based Bivalent Vaccine Effectively Protects against Both SARS-CoV-2 and Influenza A Virus Infection.
    Ao Z; Ouyang MJ; Olukitibi TA; Warner B; Vendramelli R; Truong T; Meilleur C; Zhang M; Kung S; Fowke KR; Kobasa D; Yao X
    J Virol; 2022 Sep; 96(18):e0133722. PubMed ID: 36069551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A single dose of recombinant VSV-∆G-spike vaccine provides protection against SARS-CoV-2 challenge.
    Yahalom-Ronen Y; Tamir H; Melamed S; Politi B; Shifman O; Achdout H; Vitner EB; Israeli O; Milrot E; Stein D; Cohen-Gihon I; Lazar S; Gutman H; Glinert I; Cherry L; Vagima Y; Lazar S; Weiss S; Ben-Shmuel A; Avraham R; Puni R; Lupu E; Bar-David E; Sittner A; Erez N; Zichel R; Mamroud E; Mazor O; Levy H; Laskar O; Yitzhaki S; Shapira SC; Zvi A; Beth-Din A; Paran N; Israely T
    Nat Commun; 2020 Dec; 11(1):6402. PubMed ID: 33328475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vesicular stomatitis virus pseudotyped with severe acute respiratory syndrome coronavirus spike protein.
    Fukushi S; Mizutani T; Saijo M; Matsuyama S; Miyajima N; Taguchi F; Itamura S; Kurane I; Morikawa S
    J Gen Virol; 2005 Aug; 86(Pt 8):2269-2274. PubMed ID: 16033974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term protection from SARS coronavirus infection conferred by a single immunization with an attenuated VSV-based vaccine.
    Kapadia SU; Rose JK; Lamirande E; Vogel L; Subbarao K; Roberts A
    Virology; 2005 Sep; 340(2):174-82. PubMed ID: 16043204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of Replication-Competent VSV- and Ervebo-Vectored Vaccines Against SARS-CoV-2.
    Liu Q; Ding Z; Lan J; Wong G
    Methods Mol Biol; 2022; 2410():193-208. PubMed ID: 34914048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity and protective efficacy of SARS-CoV-2 recombinant S-protein vaccine S-268019-b in cynomolgus monkeys.
    Hashimoto M; Nagata N; Homma T; Maeda H; Dohi K; Seki NM; Yoshihara K; Iwata-Yoshikawa N; Shiwa-Sudo N; Sakai Y; Shirakura M; Kishida N; Arita T; Suzuki Y; Watanabe S; Asanuma H; Sonoyama T; Suzuki T; Omoto S; Hasegawa H
    Vaccine; 2022 Jul; 40(31):4231-4241. PubMed ID: 35691872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safe and effective two-in-one replicon-and-VLP minispike vaccine for COVID-19: Protection of mice after a single immunization.
    Hennrich AA; Sawatsky B; Santos-Mandujano R; Banda DH; Oberhuber M; Schopf A; Pfaffinger V; Wittwer K; Riedel C; Pfaller CK; Conzelmann KK
    PLoS Pathog; 2021 Apr; 17(4):e1009064. PubMed ID: 33882114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of Single-Dose VSV-Based COVID-19 Vaccination in Hamsters.
    O'Donnell KL; Clancy CS; Griffin AJ; Shifflett K; Gourdine T; Thomas T; Long CM; Furuyama W; Marzi A
    Front Immunol; 2021; 12():788235. PubMed ID: 35069564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A human cell-based SARS-CoV-2 vaccine elicits potent neutralizing antibody responses and protects mice from SARS-CoV-2 challenge.
    He X; Ding L; Cao K; Peng H; Gu C; Li Y; Li D; Dong L; Hong X; Wang X; Fu M; Qiu C; Zhu C; Zhang Z; Song S; Wang C; Jiang Z; Xie Y; Qi Z; Zhao C; Zhao P; Zhang X; Xu J
    Emerg Microbes Infect; 2021 Dec; 10(1):1555-1573. PubMed ID: 34304724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.